Clinical Trial Update: A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a diphtheria, tetanus and acellular pertussis vaccine adsorbed (DTcP) developed by CanSino Biologics; the study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• DTcP vaccine (three components) adsorbed (Diphtheria, tetanus and acellular pertussis vaccine, adsorbed)

Snippet

Sponsor: CanSino Biologics Inc. | Conditions: Diphtheria, Tetanus and Acellular Pertussis | Phase 3 | Status: ACTIVE_NOT_RECRUITING